Experiment 67625
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | WILLIAMSON,L: ILLINGWORTH,H: SMITH,D: MOWAT,A:. (2000). ORAL QUININE IN ANKYLOSING SPONDYLITIS: A RANDOMIZED PLACEBO CONTROLLED DOUBLE BLIND CROSSOVER TRIAL.. 27(8) |
| Amount utilized | |
| Compound isolated | |
| Disease | FOLLOWING THE ADMINISTRATION OF ORAL QUININE (200 MG) TO 21 PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) IN A 14 WK DOUBLE-BLIND CROSSOVER STUDY, ONLY 2 PATIENTS NOTED MARKED IMPROVEMENT DURING THEIR QUININE TREATMENT PERIOD, WITH RETURN OF SYMPTOMS AFTER STOPPING THE DRUG. |
| Dose amount | 200.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |